Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandan Palani

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Topics in Medicinal Chemistry|May 29, 2003
Structure-activity relationship studies: M2 and CCR5 receptor antagonistsCraig D Boyle, Anandan Palani
Organic Letters|May 26, 2007
The total synthesis of psymberinXianhai Huang, Ning Shao, Anandan Palani, et al.
Organic Letters|December 4, 2004
Manipulation of N,O-nucleophilicity: efficient formation of 4-N-substituted 2,4-dihydro-3H-1,2,4-triazolin-3-onesXianhai Huang, Anandan Palani, Dong Xiao, et al.
Organic Letters|February 10, 2009
The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogsXianhai Huang, Ning Shao, Robert Huryk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) InhibitorsJun Qin, Pawan Dhondi, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonistsAnandan Palani, Sherry Shapiro, Mark D McBriar, et al.
The Journal of Organic Chemistry|July 16, 2013
Ligand-dependent site-selective Suzuki cross-coupling of 3,5-dichloropyridazinesXing Dai, Yonggang Chen, Stephanie Garrell, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonistsAnandan Palani, Sundeep Dugar, John W Clader, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2020
Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5BDong Xiao, Xing Dai, Hong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamidesAnandan Palani, Sherry Shapiro, John W Clader, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Topics in Medicinal Chemistry|May 29, 2003
Structure-activity relationship studies: M2 and CCR5 receptor antagonistsCraig D Boyle, Anandan Palani
Organic Letters|May 26, 2007
The total synthesis of psymberinXianhai Huang, Ning Shao, Anandan Palani, et al.
Organic Letters|December 4, 2004
Manipulation of N,O-nucleophilicity: efficient formation of 4-N-substituted 2,4-dihydro-3H-1,2,4-triazolin-3-onesXianhai Huang, Anandan Palani, Dong Xiao, et al.
Organic Letters|February 10, 2009
The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogsXianhai Huang, Ning Shao, Robert Huryk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) InhibitorsJun Qin, Pawan Dhondi, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonistsAnandan Palani, Sherry Shapiro, Mark D McBriar, et al.
The Journal of Organic Chemistry|July 16, 2013
Ligand-dependent site-selective Suzuki cross-coupling of 3,5-dichloropyridazinesXing Dai, Yonggang Chen, Stephanie Garrell, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonistsAnandan Palani, Sundeep Dugar, John W Clader, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2020
Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5BDong Xiao, Xing Dai, Hong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamidesAnandan Palani, Sherry Shapiro, John W Clader, et al.
Pageof 6